✦ LIBER ✦

Trazodone for the treatment of fibromyalgia: an open-label, 12-week study

✍ Scribed by Piedad Morillas-Arques; Carmen Ma Rodriguez-Lopez; Rocio Molina-Barea; Fernando Rico-Villademoros; Elena P Calandre

Book ID: 115016673
Publisher: BioMed Central
Year: 2010
Tongue: English
Weight: 260 KB
Volume: 11
Category: Article
ISSN: 1471-2474
DOI: 10.1186/1471-2474-11-204

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.2.c.006 Trazodone in the treatment of

P.2.c.006 Trazodone in the treatment of fibromyalgia: a 12 weeks open label study

✍ R. Molina-Barea; E.P. Calandre; P. Morillas-Arques; C.M. Rodriguez-Lopez; J.M. G 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 68 KB

P.2.g.010 Trazodone in the treatment of

P.2.g.010 Trazodone in the treatment of fibromyalgia: an interim analysis of a 12-week study

✍ E. Calandre; C.M. Rodriguez-Lopez; F. Rico-Villademoros; M. Galvez 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

An open-label study of quetiapine in the

An open-label study of quetiapine in the treatment of fibromyalgia

✍ Javier Hidalgo; Fernando Rico-Villademoros; Elena Pita Calandre 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 202 KB

A three-year, open-label, flexible-dosin

A three-year, open-label, flexible-dosing study of milnacipran for the treatment of fibromyalgia

✍ L. Arnold; A. Spera; A. Baldecchi; Y. Wang 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 31 KB

A 12-week randomized, open-label study o

A 12-week randomized, open-label study of perospirone versus aripiprazole in the treatment of Japanese schizophrenia patients

✍ Yoshiteru Takekita; Masaki Kato; Masataka Wakeno; Shiho Sakai; Azusa Suwa; Keiic 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 242 KB

Safety and efficacy of olanzapine monoth

Safety and efficacy of olanzapine monotherapy in treatment-resistant bipolar mania: a 12-week open-label study

✍ Jun Chen; David J. Muzina; David E. Kemp; Carla Conroy; Philip Chan; Mary Beth S 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB

## Objective To examine the safety and efficacy of olanzapine monotherapy in treatment‐resistant bipolar mania. ## Method Subjects (__n__ = 18) who were acutely manic, did not respond to lithium, anticonvulsants, and neuroleptics, and/or had intolerable side effects to them in previous manic epis